Dupilumab under FDA review for atopic dermatitis in children aged 6 months to 5 yearsFebruary 10, 2022Dermatology
Questions about optimal dosing of isotretinoin persist, expert saysFebruary 4, 2022DermatologyAdolescent Medicine
New AAD guidelines eye comorbidities in adults with atopic dermatitisJanuary 28, 2022Mixed TopicsDermatology
Perception of atopic dermatitis severity often differs between patients, physiciansJanuary 28, 2022Dermatology
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitisJanuary 14, 2022Dermatology
FDA updates status of iPLEDGE access problemsJanuary 14, 2022DermatologyAdolescent MedicineMixed Topics
Sorting out sleep complaints in children with AD can be complexJanuary 12, 2022DermatologySleep Medicine
FDA to review PDE4-inhibitor roflumilast for psoriasisDecember 30, 2021DermatologyAdolescent Medicine
AD burden may be greater for those with head, neck, face, and hand involvementDecember 23, 2021Dermatology
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issuesDecember 23, 2021DermatologyAdolescent Medicine
Ophthalmologist who developed medical botox dies at 89December 21, 2021Mixed TopicsNeurologyDermatology
